Telix Pharmaceuticals (ASX:TLX) Share Price and News - StockTrack

Market Cap (19-Sep) $4,607,368,192 (204th)	Close (30-Jun) $11.22 0 (0%)	Volume (30-Jun) 664,557	Shortsold (26-May) 50,730,266 (14.95%) (3rd)
52w High $26.25	52w Low $8.26	P/E 2,000.00	EPS -0.03

	Subject
	TLX TLX Ann: Release of Shares from Voluntary Escrow
	1 (current) 2 3
	TLX TLX Ann: IPAX-1 Presentation at Congress of Neurological Surgeons
	TLX TLX Ann: Cleansing Notice under S708A Corporations Act
	TLX TLX Ann: Appendix 3Y - Change of Directors Interest Notice - McCann
	TLX TLX Ann: Appendix 3Y - Change of Directors Interest Notice - Nelson
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: $12.1M R&D Tax Refund, Overseas Finding Increased to $139M
	TLX TLX Ann: FDA Extends New Drug Application Review Period for Illuccix
	TLX TLX Ann: Telix Supporting Amgen PSMA-Targeting Therapy Trial
	TLX TLX Ann: NCCN Guidelines updated to include PSMA-PET Imaging
	TLX TLX Ann: FDA Approves Phase II Kidney Cancer Therapy Study
	TLX TLX Ann: Telix and Radius sign Distribution Agreement for Italy
	TLX TLX Ann: Japanese Prostate Cancer Imaging Study Completes Enrolment
	TLX TLX Ann: Change in substantial holding
	TLX TLX Ann: Collaboration with Lightpoint Medical on Radioguided Surgery
	TLX TLX Ann: Results Presentation and Shareholder Update 1H 2021
	TLX TLX Ann: App 4D and Report for Half-Year Ended 30 June 2021
	TLX TLX Ann: GenesisCare Collaboration Expands Prostate Cancer Activity
	TLX TLX Ann: Telix and Merck pan-cancer clinical collaboration
	TLX TLX Ann: Two studies explore TLX assets in Breast Cancer Theranostics
	TLX TLX Ann: TLX66 in Phase II Academic Study of Pediatric Leukemia
	TLX TLX Ann: Telix H1 2021 Results and Company Update Conference Call
	TLX TLX Ann: 1st Patient Dosed in CUPID study of TLX592
	TLX TLX Ann: Telix Seneffe Production Facility - Progress Update
	TLX TLX Ann: App 4C and Activities Report for June 2021 Quarter
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Notification regarding unquoted securities - TLX
	TLX TLX Ann: Notification regarding unquoted securities - TLX
	TLX TLX Ann: ZIRCON Phase 3 Renal Cancer Imaging Study - Progress Update
	TLX TLX Ann: Ky Williamson to lead corporate communications and IR
	TLX TLX Ann: Change in substantial holding
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: Cleansing Notice - issue of shares upon exercise of options
	TLX TLX Ann: 1st patient dosed in TLX250-CDx study in Bladder Cancer
	TLX TLX Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update
	TLX TLX Ann: Update on FDA New Drug Application Review for Illuccix
	TLX TLX Ann: Telix and ATS $1.56M Eurostars Grant for Alpha Therapy
	TLX TLX Ann: US Co-Promotion with EZAG for Prostate Cancer Imaging
	TLX TLX Ann: Presentation to Jefferies Healthcare Conference
	TLX TLX Ann: Shareholder Update - TRALA Trial of TLX66 in SALA
	TLX TLX Ann: TLX66 Meets Study Objectives in Patients with AL Amyloidosis
	TLX TLX Ann: 1st Patient Dosed in Japanese Prostate Cancer Imaging Study
	TLX TLX Ann: German Distribution Agreement with Eckert and Ziegler
	TLX TLX Ann: App 3Y - issue of CEO options following Shareholder approval
	TLX TLX Ann: AGM Results of Meeting
	TLX TLX Ann: CEOs Address to AGM

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

End of Day Prices

Date	Close	Volume	Change
18-Sep	$13.66	1,744,449	-0.03 (0.22%)
12-Sep	$13.69	2,228,951	-0.09 (0.65%)
11-Sep	$13.78	2,596,152	-0.02 (0.14%)
05-Sep	$13.80	3,788,335	+0.03 (0.22%)
04-Sep	$13.77	3,694,284	-0.38 (2.69%)
03-Sep	$14.15	2,873,425	-0.45 (3.08%)
29-Aug	$14.60	6,420,144	-0.35 (2.34%)
28-Aug	$14.95	9,018,266	-3.38 (18.44%)
22-Aug	$18.33	2,972,158	+0.23 (1.27%)
21-Aug	$18.10	3,954,177	+0.60 (3.43%)
15-Aug	$17.50	2,055,767	+0.48 (2.82%)
14-Aug	$17.02	1,709,794	-1.18 (6.48%)
07-Aug	$18.20	2,917,367	-2.85 (13.54%)
31-Jul	$21.05	1,373,921	+0.37 (1.79%)
30-Jul	$20.68	2,019,138	+0.14 (0.68%)
6 up, 9 down, and 0 flat days

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

Telix Pharmaceuticals Health Care

$11.22 -0.22 (-1.92%)

$11.22 -0.22 (-1.92%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices